一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Journal of Food Science >>article
Journal of Food Science

Journal of Food Science

IF: 3.2
Download PDF

Therapeutic potential of Lacticaseibacillus rhamnosus grx10 and its derived postbiotic through gut microbiota and MAPK/MLCK/MLC pathway‐mediated intestinal barrier repairment in ulcerative colitis

Published:24 November 2024 DOI: 10.1111/1750-3841.17550 PMID: 39581622
Huilan Ye, Xiaolin Liu, Kaifang Guan, Ying Ma, Rongmei Liu, Yuxuan Liu, Xuepeng Lv, Rongchun Wang, Qiming Li

Abstract

Lacticaseibacillus rhamnosus grx10 (grx10) has shown promising potential in promoting intestinal health as predicted by genomic and metabolomic analyses. Given the increasing prevalence of ulcerative colitis (UC) and the limitations of existing treatments, exploring alternative therapeutic strategies is essential. This study explored the therapeutic effects and underlying mechanisms of grx10 and its derived postbiotic (P-grx10) in a mouse model of dextran sulfate sodium (DSS)-induced chronic UC. The intervention with grx10 and P-grx10 significantly alleviated clinical symptoms and improved biochemical markers in UC mice. These effects included reducing the disease activity index (DAI), improving colon length and histopathological damage, decreasing the secretion of inflammatory cytokines, and preventing the reduction of antioxidant enzymes. Additionally, grx10 and P-grx10 downregulated key proteins in the Mitogen-Activated Protein Kinase (MAPK)/myosin light chain kinase (MLCK)/myosin light chain (MLC) pathway, prevented the dissociation of tight junction (TJ) proteins and E-cadherin, reduced intestinal permeability, and restored the integrity of the intestinal barrier. Furthermore, both grx10 and P-grx10 modulated the composition and abundance of gut microbiota, helping to maintain intestinal microbiome homeostasis. In conclusion, this study provided evidence regarding the role of grx10 and P-grx10 in alleviating intestinal barrier dysfunction associated with UC and restoring gut microbiota balance. Notably, P-grx10 exhibited higher anti-inflammatory activity and better restoration of intestinal barrier function, whereas the live probiotic grx10 showed a stronger regulatory effect on the gut microbiota. These findings suggest that grx10 and P-grx10 could serve as promising nutritional adjunct therapies for UC, providing novel insights into the distinct roles of probiotic and its derived postbiotic in UC treatment.

Substances (1)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Dextran Sulfate Sodium Salt 9011-18-1 (C6H7Na3O14S3)n 516 suppliers $20.80-$6960.00
天柱县| 泗水县| 全椒县| 勐海县| 凤台县| 苏尼特右旗| 津南区| 浦江县| 深水埗区| 遂昌县| 呼玛县| 乌鲁木齐县| 桐柏县| 依兰县| 花垣县| 勐海县| 柏乡县| 青浦区| 福州市| 随州市| 丰台区| 武胜县| 壤塘县| 白银市| 芜湖县| 闸北区| 泽州县| 泽普县| 牡丹江市| 五莲县| 平度市| 建湖县| 承德市| 五原县| 尚志市| 湟中县| 信丰县| 垣曲县| 准格尔旗| 开阳县| 大姚县|